Celularity Inc. Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent
Celularity Inc. (CELU) reported Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent of -0.30% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent · last filed 2026-04-30
- Celularity Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2025 was -0.30%.
- Celularity Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2024 was -1.00%, a 300.00% decline from fiscal 2023.
- Celularity Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2023 was 0.50%.
- Celularity Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2022 was -3.10%, a 1650.00% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -0.30% 10-K · filed 2026-04-30 | |
| 2024-12-31 | -1.00% 10-K · filed 2026-04-30 | 0.40% 10-K · filed 2025-05-08 |
| 2023-12-31 | 0.50% 10-K · filed 2025-05-08 | |
| 2022-12-31 | -3.10% 10-K · filed 2024-07-30 | |
| 2021-12-31 | 0.20% 10-K · filed 2023-03-31 | 2.40% 10-K · filed 2022-03-31 |
| 2020-12-31 | -1.00% 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |